Citations Report

Pharmaceutical Regulatory Affairs: Open Access : Citations & Metrics Report

Articles published in Pharmaceutical Regulatory Affairs: Open Access have been cited by esteemed scholars and scientists all around the world.

Pharmaceutical Regulatory Affairs: Open Access has got h-index 12, which means every article in Pharmaceutical Regulatory Affairs: Open Access has got 12 average citations.

Following are the list of articles that have cited the articles published in Pharmaceutical Regulatory Affairs: Open Access.

	2022	2021	2020	2019	2018
Year wise published articles	60	60	8	15	18
Year wise citations received	49	62	76	75	53

Journal total citations count	533
Journal impact factor	2.15
Journal 5 years impact factor	2.86
Journal cite score	2.85
Journal h-index	12
Journal h-index since 2018	9

Important citations

Kavyashree, Hiremath P., F. Fernandes, and P. Muragundi. "A cross-sectional study of USFDA warning letters issued for cGMP violations pertaining to medical devices." J Appl Pharm Sci 10, no. 05 (2020): 049-053. View at Publisher View at Google Scholar View at Indexing
Pohl, Pawe?, Piotr Jamróz, Anna Dzimitrowicz, and Krzysztof Gr?da. "Analiza pierwiastkowa leków i farmaceutyków." XII SEMINARIUM NAUKOWE: 10. View at Publisher View at Google Scholar View at Indexing
Aghayere, Godfrey E., and Patrick O. Igbinaduwa. "Assessment of selected heavy metals in some anti-diarrhea pharmaceutical formulations containing kaolin available in pharmacies in Benin City, Nigeria." West African Journal of Pharmacy 32, no. 1 (2021): 165-173. View at Publisher View at Google Scholar View at Indexing
Mautsoe, Relebohile, Taelo Noko, and Oriel Hlokoane. "Microbial and Heavy Metal Contaminants in Herbal Preparations Sold in Maseru, Lesotho." International Journal of Pharmacy and Chemistry 7, no. 4 (2021): 71. View at Publisher View at Google Scholar View at Indexing
Beltifa, Asma, Sana Alibi, Vincenzo Lo Turco, Hedi Ben Mansour, and Giuseppa Di Bella. "Identification and quantification of plasticizers, bisphenol, and environmental toxic mineral elements residues in medicines from Tunisian markets." Environmental Science and Pollution Research (2021): 1-9. View at Publisher View at Google Scholar View at Indexing
Bokov, D. O., O. G. Potanina, A. V. Nikulin, V. M. Shchukin, V. A. Orlova, G. B. Bagirova, S. D. Kakhramanova et al. "Modern approaches to the analysis of kelp (Laminaria sp.) as pharmacopoeial herbal drugs and food products." Pharmacognosy Journal 12, no. 4 (2020). View at Publisher View at Google Scholar View at Indexing
Carpentier, Florian, François-Xavier Felpin, Françoise Zammattio, and Erwan Le Grognec. "Synthesis of 5-Substituted 1 H-Tetrazoles from Nitriles by Continuous Flow: Application to the Synthesis of Valsartan." Organic Process Research & Development 24, no. 5 (2020): 752-761. View at Publisher View at Google Scholar View at Indexing
Maithani, M., R. Raturi, P. Sharma, V. Gupta, and P. Bansal. "Elemental impurities in pharmaceutical products adding fuel to the fire." Regulatory Toxicology and Pharmacology 108 (2019): 104435. View at Publisher View at Google Scholar View at Indexing
Chrétien, Jean?Mathieu, Gaelle Kerric, Françoise Zammattio, Nicolas Galland, Michael Paris, Jean?Paul Quintard, and Erwan Le Grognec. "Tin?Catalyzed Synthesis of 5?Substituted 1H?Tetrazoles from Nitriles: Homogeneous and Heterogeneous Procedures." Advanced Synthesis & Catalysis 361, no. 4 (2019): 747-757. View at Publisher View at Google Scholar View at Indexing
Pohl, Pawel, Aleksandra Bielawska-Pohl, Anna Dzimitrowicz, Piotr Jamroz, and Maja Welna. "Impact and practicability of recently introduced requirements on elemental impurities." TrAC Trends in Analytical Chemistry 101 (2018): 43-55. View at Publisher View at Google Scholar View at Indexing
Ansi, V. A., and N. K. Renuka. "Table sugar derived Carbon dot–a naked eye sensor for toxic Pb2+ ions." Sensors and Actuators B: Chemical 264 (2018): 67-75. View at Publisher View at Google Scholar View at Indexing
Hole, Glenn, Anastasia S. Hole, and Ian McFalone-Shaw. "Digitalization in pharmaceutical industry: What to focus on under the digital implementation process?." International Journal of Pharmaceutics: X 3 (2021): 100095. View at Publisher View at Google Scholar View at Indexing
Kumar, Nirmal, and Ajeya Jha. "Application of principles of supply chain management to the pharmaceutical good transportation practices." International Journal of Pharmaceutical and Healthcare Marketing (2019). View at Publisher View at Google Scholar View at Indexing
Raveendrashenoy, Rujitha Thammanathuparambil. "Role of Patents in Biosimilar Drug Development and Public Interest." J. Sci. Res. 9, no. 2s (2020): s37-s47. View at Publisher View at Google Scholar View at Indexing
Natarajan, Aparna, Nikita Mehra, and Thangarajan Rajkumar. "Economic perspective of cancer treatment in India." Medical Oncology 37, no. 11 (2020): 1-7. View at Publisher View at Google Scholar View at Indexing
SINDKHEDKAR, MILIND, SANDEEP JAGTAP, CHIRAG SHAH, and VENKATA P. PALLE. "Pharmaceutical Research in India: Current Status and Opportunities." In Proc Indian Natn Sci Acad, vol. 86, no. 2, pp. 1015-1022. 2020. View at Publisher View at Google Scholar View at Indexing
Majumder, Srinanda, and Madhumita Nandi. "Biologics to Biosimilars: Bombshell to Boon!." The Child and Newborn: 16. View at Publisher View at Google Scholar View at Indexing
Pradhan, Gauri, J. M. Sneha, Babasaheb P. Sonwane, B. Santhakumari, Alka Rao, and Mahesh J. Kulkarni. "Multiple-parallel-protease digestion coupled with high-resolution mass spectrometry: An approach towards comprehensive peptide mapping of therapeutic mAbs." Journal of proteomics 232 (2021): 104053. View at Publisher View at Google Scholar View at Indexing
Esteban, Efraín, Rosa-Helena Bustos, Julio-César García, and Edwin Jáuregui. "Biosimilars: an approach to some current worldwide regulation frameworks." Current clinical pharmacology 14, no. 1 (2019): 16-40. View at Publisher View at Google Scholar View at Indexing
Rahalkar, Hasumati, Hacer Coskun Cetintas, and Sam Salek. "Quality, non-clinical and clinical considerations for biosimilar monoclonal antibody development: EU, WHO, USA, Canada, and BRICS-TM regulatory guidelines." Frontiers in pharmacology 9 (2018): 1079. View at Publisher View at Google Scholar View at Indexing
Prev 1 2 3 4 5 6 7 8 9 10 11 Next »

Relevant Topics

Awards & Nominations

50+ Million Readerbase

Journal Highlights

Google Scholar citation report

Citations: 533

Pharmaceutical Regulatory Affairs: Open Access received 533 citations as per Google Scholar report

Pharmaceutical Regulatory Affairs: Open Access

Citations Report

Pharmaceutical Regulatory Affairs: Open Access : Citations & Metrics Report

Important citations

Kavyashree, Hiremath P., F. Fernandes, and P. Muragundi. "A cross-sectional study of USFDA warning letters issued for cGMP violations pertaining to medical devices." J Appl Pharm Sci 10, no. 05 (2020): 049-053.

Pohl, Pawe?, Piotr Jamróz, Anna Dzimitrowicz, and Krzysztof Gr?da. "Analiza pierwiastkowa leków i farmaceutyków." XII SEMINARIUM NAUKOWE: 10.

Aghayere, Godfrey E., and Patrick O. Igbinaduwa. "Assessment of selected heavy metals in some anti-diarrhea pharmaceutical formulations containing kaolin available in pharmacies in Benin City, Nigeria." West African Journal of Pharmacy 32, no. 1 (2021): 165-173.

Mautsoe, Relebohile, Taelo Noko, and Oriel Hlokoane. "Microbial and Heavy Metal Contaminants in Herbal Preparations Sold in Maseru, Lesotho." International Journal of Pharmacy and Chemistry 7, no. 4 (2021): 71.

Beltifa, Asma, Sana Alibi, Vincenzo Lo Turco, Hedi Ben Mansour, and Giuseppa Di Bella. "Identification and quantification of plasticizers, bisphenol, and environmental toxic mineral elements residues in medicines from Tunisian markets." Environmental Science and Pollution Research (2021): 1-9.

Bokov, D. O., O. G. Potanina, A. V. Nikulin, V. M. Shchukin, V. A. Orlova, G. B. Bagirova, S. D. Kakhramanova et al. "Modern approaches to the analysis of kelp (Laminaria sp.) as pharmacopoeial herbal drugs and food products." Pharmacognosy Journal 12, no. 4 (2020).

Carpentier, Florian, François-Xavier Felpin, Françoise Zammattio, and Erwan Le Grognec. "Synthesis of 5-Substituted 1 H-Tetrazoles from Nitriles by Continuous Flow: Application to the Synthesis of Valsartan." Organic Process Research & Development 24, no. 5 (2020): 752-761.

Maithani, M., R. Raturi, P. Sharma, V. Gupta, and P. Bansal. "Elemental impurities in pharmaceutical products adding fuel to the fire." Regulatory Toxicology and Pharmacology 108 (2019): 104435.

Pohl, Pawel, Aleksandra Bielawska-Pohl, Anna Dzimitrowicz, Piotr Jamroz, and Maja Welna. "Impact and practicability of recently introduced requirements on elemental impurities." TrAC Trends in Analytical Chemistry 101 (2018): 43-55.

Ansi, V. A., and N. K. Renuka. "Table sugar derived Carbon dot–a naked eye sensor for toxic Pb2+ ions." Sensors and Actuators B: Chemical 264 (2018): 67-75.

Hole, Glenn, Anastasia S. Hole, and Ian McFalone-Shaw. "Digitalization in pharmaceutical industry: What to focus on under the digital implementation process?." International Journal of Pharmaceutics: X 3 (2021): 100095.

Kumar, Nirmal, and Ajeya Jha. "Application of principles of supply chain management to the pharmaceutical good transportation practices." International Journal of Pharmaceutical and Healthcare Marketing (2019).

Raveendrashenoy, Rujitha Thammanathuparambil. "Role of Patents in Biosimilar Drug Development and Public Interest." J. Sci. Res. 9, no. 2s (2020): s37-s47.

Natarajan, Aparna, Nikita Mehra, and Thangarajan Rajkumar. "Economic perspective of cancer treatment in India." Medical Oncology 37, no. 11 (2020): 1-7.

SINDKHEDKAR, MILIND, SANDEEP JAGTAP, CHIRAG SHAH, and VENKATA P. PALLE. "Pharmaceutical Research in India: Current Status and Opportunities." In Proc Indian Natn Sci Acad, vol. 86, no. 2, pp. 1015-1022. 2020.

Majumder, Srinanda, and Madhumita Nandi. "Biologics to Biosimilars: Bombshell to Boon!." The Child and Newborn: 16.

Esteban, Efraín, Rosa-Helena Bustos, Julio-César García, and Edwin Jáuregui. "Biosimilars: an approach to some current worldwide regulation frameworks." Current clinical pharmacology 14, no. 1 (2019): 16-40.

Rahalkar, Hasumati, Hacer Coskun Cetintas, and Sam Salek. "Quality, non-clinical and clinical considerations for biosimilar monoclonal antibody development: EU, WHO, USA, Canada, and BRICS-TM regulatory guidelines." Frontiers in pharmacology 9 (2018): 1079.

Relevant Topics

Awards & Nominations

50+ Million Readerbase

Journal Highlights

Google Scholar citation report

Citations: 533

Pharmaceutical Regulatory Affairs: Open Access peer review process verified at publons

Indexed In

Related Links

PMC/PubMed Indexed Articles

Open Access Journals